Particle.news
Download on the App Store
5 ARTICLES
·
2w ago

Cencora Commits Over $1 Billion to U.S. Drug Distribution Buildout Through 2030

The expansion targets soaring cold‑chain demand for specialty medicines, aligning with U.S. efforts to bolster domestic drug supply resilience.

U.S. dollar banknotes and medicines are seen in this illustration taken, June 27, 2024. REUTERS/Dado Ruvic/Illustration//File Photo
Image
The company is expanding its cold chain capacity at its Dothan distribution centre dedicated to specialty medicines. Credit: Corona Borealis Studio/Shutterstock.com.

Overview

  • Cencora will add a 530,000‑square‑foot national hub in Harrison, Ohio, slated to be fully operational by spring 2027 with advanced automation such as robotics, AI and autonomous mobile robots.
  • A 430,000‑square‑foot distribution center in Fontana, California, is planned for the West Coast, targeted to open by fall 2026 and nearly doubling the size of the current site.
  • The company is expanding its Dothan, Alabama, specialty facility by 122,500 square feet, lifting refrigerated capacity 500% and frozen capacity 200%, with completion expected by year‑end.
  • Cencora reported adjusted fourth‑quarter earnings of $3.84 per share on $83.73 billion in sales and guided 2026 adjusted EPS to $17.45–$17.75.
  • Management said demand from GLP‑1 drugs and other specialty therapies is driving capacity needs, and a strategic review is underway for non‑core assets including animal health, legacy U.S. hub services and a Brazil equity stake.